Connect public, paid and private patent data with Google Patents Public Datasets

Cosmetic compositions and methods comprising rhodiola rosea

Info

Publication number
CA2571394A1
CA2571394A1 CA 2571394 CA2571394A CA2571394A1 CA 2571394 A1 CA2571394 A1 CA 2571394A1 CA 2571394 CA2571394 CA 2571394 CA 2571394 A CA2571394 A CA 2571394A CA 2571394 A1 CA2571394 A1 CA 2571394A1
Authority
CA
Grant status
Application
Patent type
Prior art keywords
composition
cosmetic
extract
method
rosavin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2571394
Other languages
French (fr)
Other versions
CA2571394C (en )
Inventor
Thomas Mammone
Mindy Goldstein
Chia-Wen Chen
David Gan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
E-L Management Corp
Original Assignee
E-L Management Corp.
Thomas Mammone
Mindy Goldstein
Chia-Wen Chen
David Gan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/41Crassulaceae (Stonecrop family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/96Cosmetics or similar toilet preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toilet preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Abstract

A cosmetic composition comprising a UV-protective amount of at least one rosavin, preferably present in an extract of Rhodiola rosea in a cosmetically acceptable vehicle, and methods of use thereof, including preventing or reducing the signs of photoaging.

Claims (28)

1. A cosmetic composition comprising an effective amount of:
at least one rosavin; and a cosmetically acceptable vehicle.
2. The composition of claim 1 wherein the rosavin is selected from the group consisting of rosarin, rosin and mixtures thereof.
3. The composition of claim 1 which comprises from 0.0001 % to 0.1 % by weight of rosavins.
4. The cosmetic composition of claim 1 further comprising a salidroside.
5. The cosmetic composition of claim 1 further comprising at least from 0.001%
to 0.1%
of tyrosol.
6. The cosmetic composition of claim 1 further comprising a sunscreen selected from the group consisting of water soluble sunscreens, oil soluble sunscreens, inorganic sunscreens, and organic sunscreens.
7. The cosmetic composition of claim 1 wherein the rosavin is provided as part of a rosavin-containing plant extract.
8. The cosmetic composition of claim 7 wherein the plant extract is an extract of Rhodiola rosea.
9. The cosmetic composition of claim 8 wherein the extract of Rhodiola rosea comprises from 1% to 50% rosavins.
10. The cosmetic composition of claim 9 wherein the extract also contains from 0.1% to 50% salidrosides.
11. A cosmetic composition comprising:

an extract of Rhodiola rosea wherein the extract comprises an effective amount of at least one rosavin; and a cosmetically acceptable vehicle.
12. The cosmetic composition of claim 11 further comprising at least 0.1 %
salidrosides.
13. The cosmetic composition of claim 11 further comprising at least from 0.001 % to 0.1 %
of tyrosol.
14. The cosmetic composition of claim 11 further comprising a sunscreen selected from the group consisting of water soluble sunscreens, oil soluble sunscreens, inorganic sunscreens, and organic sunscreens.
15. The cosmetic composition of claim 11 wherein the extract of Rhodiola rosea comprises from 1% to 50% rosavins and from 0.1 to 50% salidrosides.
16. A method of reducing the signs of photoaging on the skin comprising a step of applying a composition comprising an effective amount of at least one rosavin;
and a cosmetically acceptable vehicle.
17. The method of claim 16 wherein the composition further comprises a sunscreen.
18. The method of claim 16 wherein the rosavin is extracted from a root of Rhodiola rosea.
19. The method of claim 16 wherein extract of Rhodiola rosea comprises from 1%
to 50%
rosavins and from 0.1 to 50% salidrosides.
20. A method of inhibiting the effects of UV exposure on the skin comprising applying to the skin a cosmetic composition comprising at least one rosavin in a cosmetically acceptable vehicle.
21. The method of claim 20 wherein the composition further comprises a sunscreen.
22. The method of claim 20 wherein the rosavin is extracted from a root of Rhodiola rosea.
23. The method of claim 20 wherein the extract of Rhodiola rosea comprises from 1% to 50% rosavins and from 0.1 to 50% salidrosides.
24. A method of alleviating the effects of UV induced damage on the skin comprising applying to the skin a cosmetic composition comprising at least one rosavin and a cosmetically acceptable vehicle.
25. The method of claim 24 wherein the composition further comprises a sunscreen.
26. The method of claim 24 wherein the rosavin is provided as part of a rosavin-containing plant extract.
27. The method of claim 26 wherein the plant extract is an extract of Rhodiola rosea.
28. The method of claim 26 wherein extract of Rhodiola rosea comprises from 1%
to 50%
rosavins and from 0.1 to 50% salidrosides.
CA 2571394 2004-06-30 2005-06-27 Cosmetic compositions and methods comprising rhodiola rosea Active CA2571394C (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US58421404 true 2004-06-30 2004-06-30
US60/584,214 2004-06-30
PCT/US2005/022811 WO2006004695A3 (en) 2004-06-30 2005-06-27 Cosmetic compositions and methods comprising rhodiola rosea

Publications (2)

Publication Number Publication Date
CA2571394A1 true true CA2571394A1 (en) 2006-01-12
CA2571394C CA2571394C (en) 2012-01-03

Family

ID=35783297

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2571394 Active CA2571394C (en) 2004-06-30 2005-06-27 Cosmetic compositions and methods comprising rhodiola rosea

Country Status (7)

Country Link
US (3) US7449203B2 (en)
JP (2) JP2008505086A (en)
KR (1) KR100882089B1 (en)
CA (1) CA2571394C (en)
EP (1) EP1768685B1 (en)
ES (1) ES2534603T3 (en)
WO (1) WO2006004695A3 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090011048A1 (en) * 2002-04-16 2009-01-08 Coleman Henry D Dietary Supplement For Promoting Removal Of Heavy Metals From The Body
US8158111B2 (en) * 2005-09-09 2012-04-17 Natura Cosmeticos S.A. Cosmetic composition and a process for preparing said composition
FR2903308B1 (en) * 2006-07-06 2011-07-29 Clarins Lab Use of a cosmetic composition for fighting against the effects of electromagnetic waves on the skin
US20090170946A1 (en) * 2007-12-27 2009-07-02 Podlipskiy Vladimir Y Composition for Mold Remediation
KR101063333B1 (en) 2008-08-29 2011-09-07 (주)아모레퍼시픽 Hypo detergent composition
KR101655146B1 (en) * 2009-08-31 2016-09-08 (주)아모레퍼시픽 Composition containing glycoproteins extract from plant
CN103462820A (en) * 2013-09-17 2013-12-25 上海应用技术学院 Anti-wrinkle hydrating smoothing toner and preparation method thereof

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
CN1091279A (en) 1993-02-26 1994-08-31 赵祖熙 Health rhodiola cosmetics and its processing technology
CN1031861C (en) 1993-04-23 1996-05-29 王业富 Rhodiola rosea hair-growth promoting liquor
CN1095919A (en) 1993-06-01 1994-12-07 北京市奥飞达科技公司 Rhodiola serial cosmetics
US5641480A (en) 1994-12-08 1997-06-24 Lever Brothers Company, Division Of Conopco, Inc. Hair care compositions comprising heteroatom containing alkyl aldonamide compounds
US5653970A (en) 1994-12-08 1997-08-05 Lever Brothers Company, Division Of Conopco, Inc. Personal product compositions comprising heteroatom containing alkyl aldonamide compounds
RU2137488C1 (en) 1996-08-20 1999-09-20 Санкт-Петербургский государственный медицинский университет им.акад.И.П.Павлова Rosewort as antibacterial agent
WO1998055075A3 (en) 1997-06-04 1999-06-17 Univ Michigan Compositions and methods for inhibiting photoaging of skin
CA2268190A1 (en) 1997-08-06 1999-02-18 Suntory Limited 1-aryl-1,8-naphthylidin-4-one derivative as type iv phosphodiesterase inhibitor
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
US6132724A (en) 1998-04-29 2000-10-17 City Of Hope National Medical Center Allelic polygene diagnosis of reward deficiency syndrome and treatment
JPH11335236A (en) 1998-05-22 1999-12-07 Shiseido Co Ltd Skin lotion
DE69917784T2 (en) 1998-07-30 2004-12-02 Vital Living, Inc., Phoenix Liquid chitosan-containing compositions and methods for making and using
US6110451A (en) 1998-12-18 2000-08-29 Calgon Corporation Synergistic combination of cationic and ampholytic polymers for cleansing and/or conditioning keratin based substrates
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
JP2001048768A (en) 1999-08-04 2001-02-20 Mikimoto Pharmaceut Co Ltd Cosmetic, quasi-drug, drug and food
US6974796B1 (en) * 1999-08-17 2005-12-13 Girsh Leonard S Therapeutic compositions for treatment of a damaged tissue
CN1158067C (en) 2000-02-03 2004-07-21 上海家化联合股份有限公司 Skin wrinkler resisting composition
US6503496B2 (en) * 2000-04-07 2003-01-07 Gerard Mildenberger Non-alcoholic and hypoallergenic face cream for the treatment of razor bumps
US6399116B1 (en) 2000-04-28 2002-06-04 Rulin Xiu Rhodiola and used thereof
JP2001316239A (en) 2000-05-10 2001-11-13 Mikimoto Pharmaceut Co Ltd Skin care preparation
JP2001316221A (en) * 2000-05-10 2001-11-13 Naris Cosmetics Co Ltd Antiaging agent and cosmetic
JP2002020301A (en) * 2000-06-29 2002-01-23 Nagaoka Koryo Kk Active oxygen eliminant, skin care agent and deodorant
US6566313B1 (en) 2000-09-15 2003-05-20 Henkel Corporation Shampoo and body wash composition and method of use thereof
DE10053053A1 (en) * 2000-10-19 2002-05-16 Knoell Hans Forschung Ev Pharmaceutical formulations for the inhibition of inflammatory arthritides
CN1561220A (en) * 2000-11-08 2005-01-05 普罗米蒂克生物科学公司 Method for the treatment of inflammation
KR20010016591A (en) 2000-12-23 2001-03-05 장홍선 A manufacturing of Rhodiola sachalinensis A. Bor and a use
CN1217696C (en) 2001-01-11 2005-09-07 王东桥 Health caring and face nursing composition of natural materials
US6551627B1 (en) * 2001-05-03 2003-04-22 Holomed Pharmaceuticals, Ltd. Medicinal herbal compounds for the prevention and treatment of diabetes
KR100445404B1 (en) 2001-08-01 2004-08-25 주식회사 웰스킨 Whitening composition containing rhodiola sachalinensis a. bor extraction
GB0204387D0 (en) * 2002-02-26 2002-04-10 Secr Defence Screening process
JP2003261435A (en) * 2002-03-11 2003-09-16 Ichimaru Pharcos Co Ltd Energy modifying agent
RU2211692C1 (en) 2002-05-06 2003-09-10 Аникеев Сергей Владимирович Skin face and bode care cream
JP2004002237A (en) * 2002-05-31 2004-01-08 Amano Jitsugyo Kk Anti-aging herb
WO2004012669A3 (en) * 2002-08-01 2006-02-02 Us Gov Health & Human Serv Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
US7115285B2 (en) * 2003-03-14 2006-10-03 Eurark, Llc Composition and method for appetite and craving suppression and mood enhancement
FR2852846B3 (en) * 2003-03-28 2005-02-11 Michel Frey Applying a title extracted rosavin associated with a biological principle type hydro soluble vitamin lipo, trace elements and paravitamines
US20050170013A1 (en) * 2004-02-04 2005-08-04 Douglas Jerry A. Composition for treating a dermatological inflammatory response and method of preparation thereof
US20050220912A1 (en) * 2004-03-30 2005-10-06 Theoharides Theoharis C Anti-inflammatory composition for treating pelvic endometriosis

Also Published As

Publication number Publication date Type
KR100882089B1 (en) 2007-03-15 grant
CA2571394C (en) 2012-01-03 grant
EP1768685B1 (en) 2015-01-14 grant
US20080268074A1 (en) 2008-10-30 application
EP1768685A2 (en) 2007-04-04 application
JP2008505086A (en) 2008-02-21 application
US7449203B2 (en) 2008-11-11 grant
WO2006004695A2 (en) 2006-01-12 application
US20100297042A1 (en) 2010-11-25 application
JP2010013469A (en) 2010-01-21 application
EP1768685A4 (en) 2009-07-22 application
US20060002871A1 (en) 2006-01-05 application
KR20070030310A (en) 2007-03-15 application
WO2006004695A3 (en) 2006-05-04 application
ES2534603T3 (en) 2015-04-24 grant

Similar Documents

Publication Publication Date Title
WO2009025146A1 (en) Gel composition and cosmetic preparation
WO2000051561A1 (en) Cosmetics
CA2551231A1 (en) Method for the production of an administration form which is secured against misuse
WO2005117557A3 (en) Expression system
WO2006090930A1 (en) Novel combinational use of sulfonamide compound
WO2007135461A3 (en) Pharmaceutical compositions comprising implitapide and methods of using same
WO2007089864A3 (en) Sutures and fibrosing agents
WO2005105113A3 (en) Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine
WO2007060956A1 (en) Skin care cosmetic and skin and agent for preventing skin roughness containing biosurfactants
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
WO2005074524A3 (en) Modified human interferon polypeptides and their uses
WO2002024179A3 (en) Method for reducing toxicity of combined chemotherapies
WO2008066193A1 (en) Cosmetic composition
WO2006038315A1 (en) Preparation for percutaneous/permucosal absorption
WO2005007171A1 (en) Accelerator for mineral absorption and use thereof
WO2008152858A1 (en) 6,8,10-undecatrien-(3 or 4)-one and perfume composition
WO2005042508A1 (en) PLANT-ORIGIN β3-ADRENOCEPTOR AGONIST AND USE OF THE SAME
WO2005097198A1 (en) Preparation for oral administration
WO2000045782A1 (en) TESTOSTERONE-5α-REDUCTASE INHIBITORS, HAIR GROWTH STIMULANT/HAIR NOURISHMENT COMPOSITIONS AND COMPOSITIONS FOR WHITENING COSMETICS
WO2005032530A1 (en) Pharmaceutical composition for external application
WO2007084857A3 (en) Methods and compositions for treating cell proliferative disorders
WO2007022734A1 (en) A composition for alleviating a hangover comprising hyaluronic acid and activated carbon
CA2506290C (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO2006120941A1 (en) Parakeratosis inhibitor, pore-shrinking agent and external composition for skin
WO2005065319A3 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering

Legal Events

Date Code Title Description
EEER Examination request